• Hero Banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Top Recommended Veterinary Products
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Buying or Selling a Practice
Hospital Design
Leadership & Personal Growth
Personnel Management
Practice Finances
Practice Operations
Technology
Wellbeing & Lifestyle
Continuing Education
Conferences
Live Conferences
Conference News
Conference Proceedings
Resources
CBD in Pets
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Carprofen Potentiates Activity of Doxycycline Against Methicillin-Resistant Staphylococcus pseudintermedius In Vitro

August 29, 2016
Laurie Anne Walden, DVM, ELS

Carprofen enhances the in vitro antimicrobial effect of doxycycline against methicillin-resistant Staphylococcus pseudintermedius (MRSP), according to a recent study.

Carprofen enhances the in vitro antimicrobial effect of doxycycline against methicillin-resistant Staphylococcus pseudintermedius (MRSP), according to a study recently published in BMC Veterinary Research.

MRSP poses a health risk to both humans and animals. Certain strains of MRSP are resistant to all of the main antibiotic classes used in veterinary patients. Some drugs used to treat noninfectious conditions also have in vitro antimicrobial activity, so using combinations of non-antimicrobial and antimicrobial drugs could potentially overcome bacterial resistance, write the authors.

The study included 6 antibacterial drugs (ampicillin, oxacillin, ciprofloxacin, clindamycin, doxycycline, and trimethoprim/sulfamethoxazole) and 36 non-antibacterial drugs chosen for their availability and frequency of use in veterinary practice. Investigators performed double disk infusion tests on agar plates inoculated with MRSP to identify non-antibacterial drugs that extended the antibacterial drugs’ inhibition zones. This initial screening revealed 7 non-antibacterial drugs (acepromazine, amitriptyline, bromhexine, clomipramine, carprofen, fluoxetine, and ketoconazole) that showed activity against MRSP and also appeared to potentiate the activity of at least 1 antibiotic.

Advertisement

Minimum inhibitory concentration test results showed that of the 7 non-antibacterial drugs, ketoconazole had the highest anti-MRSP activity and bromhexine had the lowest. Checkerboard assays were used to investigate the synergy of these 7 drugs with the antibiotic that they appeared to potentiate to the greatest degree. The combination of carprofen and doxycycline was the only one to show synergy.

The carprofen/doxycycline combination had a synergistic effect against strains of MRSP carrying the tetracycline resistance gene tetK but not against other strains. Synergy was achieved with concentrations of carprofen and doxycycline that were compatible with the recommended oral doses of these drugs in dogs.

The authors point out that the drug combination will not necessarily work the same way in vivo as it does in vitro. They suggest further in vitro tests to investigate serum protein binding, which could alter the in vivo effectiveness of the drug combination. A carprofen/doxycycline combination could be useful in the treatment of upper respiratory infections, they write, and topical formulations could also potentially be used to treat skin and soft-tissue infections.

The study was funded by the University of Copenhagen Research Center for Control of Antibiotic Resistance and by a grant from Zoetis.

Dr. Laurie Anne Walden received her doctorate in veterinary medicine from North Carolina State University. After an internship in small animal medicine and surgery at Auburn University, she returned to North Carolina, where she has been in small animal primary care practice for over 20 years. Dr. Walden is also a board-certified editor in the life sciences and owner of Walden Medical Writing, LLC.


Advertisement

Latest News

Oldest aardvark in Europe passes away

Integrative approach to treating Giardia lamblia infections

Innovative digital microscopy platform is launched

Enhanced pet health and wellness app now available

View More Latest News
Advertisement